Navigation Links
Exagen Diagnostics Receives Lab Accreditation From College of American Pathologists
Date:7/8/2010

ALBUQUERQUE, N.M., July 8 /PRNewswire/ -- Exagen Diagnostics, Inc., a molecular diagnostics laboratory that discovers, develops and markets proprietary genomic tests, has been awarded accreditation by the Accreditation Committee of the College of American Pathologists (CAP).

The CAP is a leading organization of board-certified pathologists that serves patients, pathologists and the public by fostering and advocating excellence in the practice of pathology and laboratory medicine. The CAP accreditation program, begun in the early 1960s, is recognized by the federal government as being equal to or more stringent than the government's own inspection program. Exagen is one of more than 17,000 CAP-accredited laboratories in the world.

"We are extremely pleased to receive recognition for the high quality diagnostic services our laboratory provides," said Exagen Clinical Laboratory Director John Hozier Ph.D., FACMG. "As we continue to develop new genomic tests independently and through partnerships with pharmaceutical and diagnostics companies, having CAP accreditation validates our position as one of the world's most forward looking laboratories."

The CAP awards accreditation based on the results of onsite inspections. During the process, inspectors examine the laboratory's records and quality control procedures for the preceding two years. CAP inspectors also examine laboratory staff qualifications, laboratory equipment, facilities, the laboratory's safety program and record, in addition to overall management of the laboratory. This stringent inspection program is specifically designed to ensure the highest standard of care for all laboratory patients.

About the College of American Pathologists

The College of American Pathologists (CAP) is a medical society that serves more than 17,000 physician members and the laboratory community throughout the world. It is the world's largest association composed exclusively of board certified pathologists and is widely considered the leader in laboratory quality assurance. The CAP is an advocate for high-quality and cost-effective patient care. More information about the CAP can be found at www.cap.org.

About Exagen Diagnostics

Exagen is the emerging leader in laboratory-discovered and developed genomic tests specifically designed to provide objective information to physicians and patients for more accurate, efficient diagnosis and better disease management. Using Coperna®, the company's proprietary, algorithm-driven computational tool and search engine that runs on high-performance computational clusters, it combines the ability to process massive amounts of data contained in genomic datasets with intelligent, rapid search methods. Coperna's targeted and precise discovery model has no conventional equivalent in the molecular diagnostics industry as it can identify relevant marker sets with superior sensitivity and specificity relative to markers identified using traditional analytical methods. For more information, please visit www.exagen.com.


'/>"/>
SOURCE Exagen Diagnostics, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Exagen Diagnostics Enters Into Exclusive Agreement With EndoChoice
2. Scott Glenn Joins Exagen Diagnostics as Chairman and CEO
3. Reportlinker Adds Personalized Medicine 2010: Assessing the Opportunities and Challenges in Commercializing Companion Diagnostics and Targeted Therapies
4. DeviceSpace Showcases Medical Device and Diagnostics Companies
5. Dominion Diagnostics Introduces CARD™: The Next-Generation Clinical Laboratory Diagnostics Tool for Addiction Treatment
6. PLUS Diagnostics Introduces Industrys First System to Eliminate Misidentification of Bone Marrow Samples
7. Distinction of Quality for Dilon Diagnostics
8. Novartis Vaccines & Diagnostics to Pay More Than $72 Million to Resolve False Claims Act Allegations Concerning TOBI
9. Ambry Genetics and RainDance Technologies Announce Partnership for Diagnostics and Genomics Services Utilizing the RDT 1000 for Sequence Enrichment and Targeted Resequencing Validation
10. Home Diagnostics Selects Parago to Deliver Consumer Incentives Focused on Best Customer Experience
11. Dilon Diagnostics Receives ISO 13485 Certification
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/27/2017)... Period October – December 2016 Revenues amounted to SEK ... million Result after tax amounted to SEK -16.3 (-6.5) million, ... Cash flow from operating activities amounted to SEK -8.3 (-7.3) million ... Period full year 2016 ... result amounted to SEK -39.5 (-29.5) million Result after tax ...
(Date:2/24/2017)... , Feb. 24, 2017 Zimmer Biomet ... in musculoskeletal healthcare, will present at the Cowen and ... the Boston Marriott Copley Place on Tuesday, March 7, ... A live webcast of the presentation can be accessed ... for replay following the conference via Zimmer Biomet,s Investor ...
(Date:2/24/2017)... Feb. 24, 2017  In conjunction with DURECT Corporation,s ... results press release, you are invited to listen to ... the internet on Tuesday, March 14, 2017 at 4:30 ... A live audio webcast of the presentation will be ... and clicking "Investor Relations."  If you are unable to ...
Breaking Medicine Technology:
(Date:2/26/2017)... , ... February 26, 2017 , ... NuevaCare, a leading ... diverse as Millbrae, Belmont, and Palo Alto, is proud to announce an important upgrade ... Area consumers look for home care close to home, and by having city-specific pages, ...
(Date:2/26/2017)... ... February 26, 2017 , ... ODH, Inc.™ announced today it ... at the Sheraton Pentagon City Hotel in Arlington, VA. ODH’s director of medical strategy, ... health analytics to improve Medicaid population health management. , ODH will also have an ...
(Date:2/24/2017)... Prior Lake MN (PRWEB) , ... February 24, ... ... the launch of its newly designed TaskMate Go. Core benefits and advantages built ... grain finish and a stylish, functional look and feel. Ability to gain the ...
(Date:2/24/2017)... ... February 24, 2017 , ... An in-depth computational analysis of genetic ... Pittsburgh points to eight genes that may explain why susceptibility to one of the ... of a study published today in the journal npj Schizophrenia. , “There is ...
(Date:2/24/2017)... ... , ... With millions of Americans and people worldwide struggling ... are aware of our options and are empowered with strength and information throughout ... its newest edition of "Vision and Hearing" in USA Today, that will educate ...
Breaking Medicine News(10 mins):